Free tool
FAERS Monitor: Alkindi Sprinkle
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 213876 or its brand name (Alkindi Sprinkle, Hydrocortisone). Reports on generic versions are filed under their own applications.
Reports
68,505
Serious
56,550
83% of reports
Hospitalization
29,123
Death reported
10,069
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use9,694
- drug ineffective7,644
- fatigue6,094
- condition aggravated5,566
- nausea5,130
- rash5,027
- diarrhoea4,568
- headache4,528
- pain4,512
- dyspnoea4,403
- arthralgia4,390
- pyrexia4,064
- vomiting4,030
- pruritus3,828
- malaise3,696
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 437 |
| 2005 | 555 |
| 2006 | 511 |
| 2007 | 547 |
| 2008 | 613 |
| 2009 | 735 |
| 2010 | 847 |
| 2011 | 1,083 |
| 2012 | 1,768 |
| 2013 | 1,542 |
| 2014 | 1,779 |
| 2015 | 2,440 |
| 2016 | 2,886 |
| 2017 | 3,318 |
| 2018 | 4,828 |
| 2019 | 4,318 |
| 2020 | 5,260 |
| 2021 | 5,540 |
| 2022 | 6,220 |
| 2023 | 6,179 |
| 2024 | 6,464 |
| 2025 | 6,284 |
| 2026 | 4,347 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,985,654 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| condition aggravatedSignal | 5,566 | 5.7 | 5.6 | 21,519 |
| pyrexiaSignal | 4,064 | 3.6 | 3.5 | 7,805 |
| rashSignal | 5,027 | 3.6 | 3.5 | 9,387 |
| off label useSignal | 9,694 | 3.4 | 3.4 | 17,181 |
| arthralgiaSignal | 4,390 | 3.3 | 3.2 | 6,963 |
| pruritusSignal | 3,828 | 3.1 | 3.0 | 5,417 |
| vomitingSignal | 4,030 | 2.6 | 2.6 | 4,182 |
| malaiseSignal | 3,696 | 2.6 | 2.5 | 3,686 |
| fatigueSignal | 6,094 | 2.4 | 2.4 | 5,200 |
| dyspnoeaSignal | 4,403 | 2.4 | 2.3 | 3,661 |
| painSignal | 4,512 | 2.3 | 2.2 | 3,256 |
| headacheSignal | 4,528 | 2.2 | 2.2 | 3,128 |
| diarrhoeaSignal | 4,568 | 2.2 | 2.1 | 2,992 |
| nausea | 5,130 | 2.0 | 1.9 | 2,633 |
| drug ineffective | 7,644 | 1.8 | 1.7 | 2,800 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.